The major driving forces behind the extensive growth of the medical perfusion technology market can be marked down to an increasing prevalence of failing organ ...

The Medical Perfusion Technology Market Growth impelled by rise in prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, increase in need for ...

OrganOx could capture a greater share of the liver transplant market, where it competes with TransMedics Group, Needham ...

RESTON, Va., June 16, 2025 /PRNewswire/ -- Perfusion Medical, an emerging biopharmaceutical company developing a pipeline of life-saving, acute cardiovascular therapies to transform intensive care ...

Terumo Corporation (OTCPK:TRUMF) has entered into a definitive agreement to acquire OrganOx Limited, a company specializing ...

In what is being touted as a major breakthrough, scientists have developed a machine that can not only keep livers alive outside the body for a week, but can also rejuvenate damaged livers unfit ...

In terms of revenue, the Medical Perfusion Technology market size was valued at around US$ 750.15 Million in 2020 and is projected to reach US$ 905.50 Million by 2026.

Perfusion Medical, an emerging biopharmaceutical company developing a pipeline of life-saving, acute cardiovascular therapies to transform intensive care medicine, today announced that it has received ...